Samantha G Zambuto1, Shemona Rattila2, Gabriela Dveksler2, Brendan A C Harley3,4. 1. Department of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801 USA. 2. Department of Pathology, Uniformed Services University of Health Sciences, Bethesda, MD 20814 USA. 3. Department Chemical and Biomolecular Engineering, Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, 110 Roger Adams Laboratory, 600 S. Mathews Ave, Urbana, IL 61801 USA. 4. Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801 USA.
Abstract
Introduction: Trophoblast invasion is a complex biological process necessary for establishment of pregnancy; however, much remains unknown regarding what signaling factors coordinate the extent of invasion. Pregnancy-specific glycoproteins (PSGs) are some of the most abundant circulating trophoblastic proteins in maternal blood during human pregnancy, with maternal serum concentrations rising to as high as 200-400 μg/mL at term. Methods: Here, we employ three-dimensional (3D) trophoblast motility assays consisting of trophoblast spheroids encapsulated in 3D gelatin hydrogels to quantify trophoblast outgrowth area, viability, and cytotoxicity in the presence of PSG1 and PSG9 as well as epidermal growth factor and Nodal. Results: We show PSG9 reduces trophoblast motility whereas PSG1 increases motility. Further, we assess bulk nascent protein production by encapsulated spheroids to highlight the potential of this approach to assess trophoblast response (motility, remodeling) to soluble factors and extracellular matrix cues. Conclusions: Such models provide an important platform to develop a deeper understanding of early pregnancy.
Introduction: Trophoblast invasion is a complex biological process necessary for establishment of pregnancy; however, much remains unknown regarding what signaling factors coordinate the extent of invasion. Pregnancy-specific glycoproteins (PSGs) are some of the most abundant circulating trophoblastic proteins in maternal blood during human pregnancy, with maternal serum concentrations rising to as high as 200-400 μg/mL at term. Methods: Here, we employ three-dimensional (3D) trophoblast motility assays consisting of trophoblast spheroids encapsulated in 3D gelatin hydrogels to quantify trophoblast outgrowth area, viability, and cytotoxicity in the presence of PSG1 and PSG9 as well as epidermal growth factor and Nodal. Results: We show PSG9 reduces trophoblast motility whereas PSG1 increases motility. Further, we assess bulk nascent protein production by encapsulated spheroids to highlight the potential of this approach to assess trophoblast response (motility, remodeling) to soluble factors and extracellular matrix cues. Conclusions: Such models provide an important platform to develop a deeper understanding of early pregnancy.
Authors: Sara Pedron; Amanda M Pritchard; Gretchen A Vincil; Brenda Andrade; Steven C Zimmerman; Brendan A C Harley Journal: Biomacromolecules Date: 2017-03-09 Impact factor: 6.988
Authors: Hai Wang; Silvina Bocca; Sandra Anderson; Liang Yu; Bhaskara S Rhavi; José Horcajadas; Sergio Oehninger Journal: Tissue Eng Part C Methods Date: 2013-02-19 Impact factor: 3.056
Authors: Che-Ying Kuo; Mariya Shevchuk; Justin Opfermann; Ting Guo; Marco Santoro; John P Fisher; Peter Cw Kim Journal: Biotechnol Bioeng Date: 2018-10-27 Impact factor: 4.530
Authors: Shemona Rattila; Caroline E E Dunk; Michelle Im; Olga Grichenko; Yan Zhou; Maria Yanez-Mo; Sandra M Blois; Kenneth M Yamada; Offer Erez; Nardhy Gomez-Lopez; Stephen J Lye; Boris Hinz; Roberto Romero; Marie Cohen; Gabriela Dveksler Journal: Cells Date: 2019-10-31 Impact factor: 6.600
Authors: Daniela Loessner; Christoph Meinert; Elke Kaemmerer; Laure C Martine; Kan Yue; Peter A Levett; Travis J Klein; Ferry P W Melchels; Ali Khademhosseini; Dietmar W Hutmacher Journal: Nat Protoc Date: 2016-03-17 Impact factor: 13.491